
Evolent Health (EVH) Earnings Dates & Reports
Evolent Health (EVH) Most Recent Earnings
Report Date
Period EndingQ4 2025
Est. EPS$0.02
Actual EPS$0.08
EarningsBeat
Evolent Health (EVH) Earnings
View the latest Evolent Health (EVH) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in Evolent Health (EVH)
Order type
Buy in
Order amount
Est. shares
0 shares
Evolent Health (EVH) Earnings per Share (EPS) History
Signup for full accessBrowse free
Evolent Health (EVH) Latest Earnings
The value each EVH share was expected to gain vs. the value each share gained.
Evolent Health (EVH) reported its most recent earnings on for Q4 2025, posting earnings per share (EPS) of $0.08. This exceeded analysts' expectations of $0.02 by 300.00%, marking a Beat.
For comparison, Evolent Health reported EPS of -$0.02 in the same quarter last year.
The company is expected to announce its next earnings report on , with analysts projecting an EPS of -$0.02.
Evolent Health (EVH) Earnings History
Evolent Health (EVH) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the Evolent Health’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
| Report date | Price 1D before | Price 1D after | Change |
|---|---|---|---|
| — | — | — | |
| — | — | — | |
| — | — | — | |
| — | — | — |
Evolent Health (EVH) Earnings FAQs
Evolent Health (EVH) last reported earnings on Feb 27, 2026 for Q4 2025, posting an EPS of $0.08, which Beat the estimate of $0.02 by 300.00%.
For Q4 2025, Evolent Health (EVH) reported an EPS of $0.08, exceeding analysts' estimate of $0.02 by 300.00%.
For Q4 2025, Evolent Health (EVH) Beat expectations with an actual EPS of $0.08 vs. an estimated EPS of $0.02.
Following the last earnings report on Feb 27, 2026, Evolent Health (EVH)'s stock price moved — from — to —.
The next Evolent Health (EVH) earnings call is scheduled for May. 7, 2026, where executives will discuss financial results and outlook.